5-formyl-2'-deoxyuridine has been researched along with cytidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fehm, T; Kootz, B; Neubauer, H; Schott, S; Seeger, H; Wallwiener, M | 1 |
| Giuashvili, S; Königsrainer, A; Reymond, M; Sautkin, I; Schott, TC; Struller, F; Weinreich, J | 1 |
2 other study(ies) available for 5-formyl-2'-deoxyuridine and cytidine
| Article | Year |
|---|---|
ATP chemosensitivity testing of new antitumor duplex drugs linking 3`-C-ethynylycytidine (ECyd) and 2´-deoxy-5-fluorouridine (5-FdU) in comparison to standard cytostatica and combinations thereof.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cell Proliferation; Cytidine; Deoxyuridine; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Metabolic Networks and Pathways; Reference Standards | 2011 |
Chemosensitivity of various peritoneal cancer cell lines to HIPEC and PIPAC: comparison of an experimental duplex drug to standard drug regimens in vitro.
Topics: Adult; Aged; Apoptosis; Cell Proliferation; Cisplatin; Colonic Neoplasms; Cytidine; Cytostatic Agents; Deoxyuridine; Doxorubicin; Female; Humans; Hyperthermia, Induced; In Vitro Techniques; Middle Aged; Ovarian Neoplasms; Oxaliplatin; Peritoneal Neoplasms; Stomach Neoplasms; Tumor Cells, Cultured | 2019 |